bromocriptine has been researched along with 1-methyl-4-phenylpyridinium in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Autelitano, DJ; Funder, JW; Lolait, SJ; Smith, AI | 1 |
| Kitamura, Y; Kohno, Y; Nakazawa, M; Nomura, Y | 1 |
| Kakimura, JI; Kitamura, Y; Kohno, Y; Kosaka, T; Matsuoka, Y; Nomura, Y; Taniguchi, T | 1 |
| Freed, WJ; Kishikawa, M; Takashima, H; Tsujihata, M | 1 |
| Chiasson, K; Daoust, B; Levesque, D; Martinoli, MG | 1 |
| Ganguly, A; Lee, D; Schultz, BJ; Wiemerslage, L | 1 |
6 other study(ies) available for bromocriptine and 1-methyl-4-phenylpyridinium
| Article | Year |
|---|---|
Dopaminergic agents differentially alter beta-endorphin processing patterns in the rat pituitary neurointermediate lobe.
Topics: 1-Methyl-4-phenylpyridinium; Animals; beta-Endorphin; Bromocriptine; Chromatography, High Pressure Liquid; Dopamine; Endorphins; Female; Haloperidol; Pituitary Gland, Anterior; Pyridinium Compounds; Radioimmunoassay; Rats; Rats, Inbred Strains | 1985 |
Inhibitory effects of talipexole and pramipexole on MPTP-induced dopamine reduction in the striatum of C57BL/6N mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Azepines; Benzothiazoles; Bromocriptine; Dopamine; Dopamine Agents; Dopamine Agonists; Homovanillic Acid; In Vitro Techniques; Injections, Intraperitoneal; Male; Mice; Mice, Inbred C57BL; Neostriatum; Pramipexole; Synaptosomes; Thiazoles | 1997 |
Protective effects of the antiparkinsonian drugs talipexole and pramipexole against 1-methyl-4-phenylpyridinium-induced apoptotic death in human neuroblastoma SH-SY5Y cells.
Topics: 1-Methyl-4-phenylpyridinium; Antiparkinson Agents; Apoptosis; Azepines; Benzothiazoles; Bromocriptine; Bucladesine; Caspase 3; Caspases; Dopamine Agonists; Humans; Pramipexole; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Thiazoles; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1998 |
Bromocriptine protects dopaminergic neurons from levodopa-induced toxicity by stimulating D(2)receptors.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Antiparkinson Agents; Antisense Elements (Genetics); Autoreceptors; Bromocriptine; Cell Survival; Cells, Cultured; Dopamine; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Female; Fetus; Fluoresceins; Free Radicals; Gene Expression; Levodopa; Mesencephalon; Nerve Degeneration; Neurons; Neuroprotective Agents; Neurotoxins; Pregnancy; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Sulpiride; Tyrosine 3-Monooxygenase | 1999 |
Dopamine D2 agonists, bromocriptine and quinpirole, increase MPP+ -induced toxicity in PC12 cells.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Blotting, Western; Bromocriptine; Cell Proliferation; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Drug Synergism; Gene Expression; Neurotoxins; PC12 Cells; Quinpirole; Rats; Receptors, Dopamine D2; Receptors, Dopamine D3; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2006 |
Selective degeneration of dopaminergic neurons by MPP(+) and its rescue by D2 autoreceptors in Drosophila primary culture.
Topics: 1-Methyl-4-phenylpyridinium; Action Potentials; Animals; Animals, Genetically Modified; Bromocriptine; Cholinergic Neurons; Dopamine Agonists; Dopaminergic Neurons; Drosophila melanogaster; Drosophila Proteins; Female; GABAergic Neurons; Male; Nerve Degeneration; Parkinsonian Disorders; Primary Cell Culture; Quinpirole; Receptors, Dopamine D2 | 2013 |